These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
84 related articles for article (PubMed ID: 677139)
61. Internal standards: rationale for use in a drug utilization review program. Huber SL; Patry RA Drug Intell Clin Pharm; 1981 Oct; 15(10):789-92. PubMed ID: 7285798 [TBL] [Abstract][Full Text] [Related]
62. Reducing the cost of cephalosporin therapy. de Louvois J; Harvey DR; Moore F Lancet; 1985 Jan; 1(8420):103. PubMed ID: 2857000 [No Abstract] [Full Text] [Related]
63. Cefazolin-induced hypoprothrombinemia. Smith M; Doyle J; Crane C; Bussell C Proc (Bayl Univ Med Cent); 2022; 35(6):868-870. PubMed ID: 36304595 [TBL] [Abstract][Full Text] [Related]
64. Dollar costs of conducting drug use review. Knapp DA; Palumbo FB J Am Pharm Assoc; 1977 Apr; 17(4):231-3. PubMed ID: 858887 [No Abstract] [Full Text] [Related]
65. University Groups Protest Cost Cuts: New proposals for capping overheads on federal grants draw fire from university administrators; savings, of $200 million projected for next year. Norman C Science; 1986 Mar; 231(4742):1059-60. PubMed ID: 17818529 [No Abstract] [Full Text] [Related]
68. Impact of drug usage review on drug utilisation. Blackburn JL Pharmacoeconomics; 1993 Jan; 3(1):14-21. PubMed ID: 10146984 [TBL] [Abstract][Full Text] [Related]
69. Practical strategies for the appropriate use of antimicrobials. Guglielmo BJ Pharm World Sci; 1995 Jul; 17(4):96-102. PubMed ID: 7581222 [TBL] [Abstract][Full Text] [Related]
70. Use and abuse of antibiotics. Hamilton-Miller JM Br J Clin Pharmacol; 1984 Oct; 18(4):469-74. PubMed ID: 6386026 [No Abstract] [Full Text] [Related]